jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

July. 05, 2024

Mar. 04, 2026

jRCT1011240022

An exploratory iNvestigation of rEal-World pharmacokinetics and TherApeutic drug monitoring-Guided personalized dosing of novel molEcular Targeted drugs (NEWTARGET study)

An exploratory iNvestigation of rEal-World pharmacokinetics and TherApeutic drug monitoring-Guided personalized dosing of novel molEcular Targeted drugs (NEWTARGET study)

Masahide Fukudo

Sapporo Medical University Hospital

South-1, West-16, Chuo-ku, Sapporo, Hokkaido

+81-11-688-9686

fukudom@sapmed.ac.jp

Masahide Fukudo

Sapporo Medical University Hospital

South-1, West-16, Chuo-ku, Sapporo, Hokkaido

+81-11-688-9686

fukudom@sapmed.ac.jp

Recruiting

July. 05, 2024

50

Observational

Subjects whose medical care and prognostic information can be obtained from medical records

Subjects presenting with any of the following will be excluded from the study:
1. Subjects who requested non-participation in this study based on a published opt-out document.
2. Subjects who are participating in or interested in participating in other clinical trials during the study period.

No limit
No limit

Both

Neoplasms (Lung Cancer etc.), Inflammatory Bowel Diseases, Rheumatoid Arthritis, Autoimmune Diseases

D009369, D015212, D001172, D001327

The variability of pharmacokinetics

-Pharmacokinetic linearity across doses administered
-The incidence of adverse events
-Response to treatment (clinical response and clinical remission)
-Treatment persistence rate
-Exposure-safety relationship
-Exposure-efficacy relationship

Sapporo Medical University Hospital
Institutional Review Board of Sapporo Medical University Hospital
South-1, West-16, Chuo-ku, Sapporo, Hokkaido, Hokkaido

+81-11-611-2111

ji-rskk@sapmed.ac.jp
Approval

June. 27, 2024

No

none

History of Changes

No Publication date
2 Mar. 04, 2026 (this page) Changes
1 July. 05, 2024 Detail